Triglycerides in fish oil affect the blood clearance of lipid emulsions containing long- and medium-chain triglycerides in mice.
Lipid emulsions containing long-chain triglycerides (LCT) and medium chain triglycerides (MCT) are widely used in parenteral nutrition. Recently, fish oil (FO) triglyceride (TG)-derived emulsions are considered therapeutic because of their many beneficial biological modulatory actions. We investigated in mice whether adding 10% FO to an intravenous lipid emulsion with MCT and LCT (MCT:LCT:FO -50:40:10% by wt) would affect particle blood clearance and tissue targeting in comparison to LCT (100% by wt) and MCT:LCT (50:50% by wt) emulsions. The 3 emulsions were labeled with [3H] cholesteryl oleoyl ether and administered by bolus injection (400 microg TG/mouse) to C57BL/6J mice. Contributions of LDL receptor (LDL-R) and LDL-R-related protein to emulsion catabolism were assessed using LDL-R-deficient mice and preinjection of lactoferrin, and the effects of lipoprotein lipase (LPL) were determined by preinjection of heparin and Triton WR 1339. Although fractional catabolic rates did not differ among the 3 emulsions, blood removal at each time point after injection was greater for MCT:LCT:FO particles due to their higher initial margination volume. Compared with MCT:LCT and LCT emulsions, patterns of tissue uptake of the MCT:LCT:FO emulsions were different, e.g. MCT:LCT:FO emulsion particle uptake was lower in heart, adipose tissue, and muscle, and higher in lung, and the removal of MCT:LCT:FO emulsion particles was less dependent on LPL, LDL-R, and lactoferrin-sensitive pathways. These data suggest that the addition of a low percentage of FO to MCT:LCT emulsions substantially changes their particle clearance and tissue uptake mechanisms.
Qi
Kemin
K
Clinical Nutrition Center, Beijing Children's Hospital, The Capital University of Medical Sciences, Beijing, China. qkm6@hotmail.com
Seo
Toru
T
Jiang
Zaifang
Z
Carpentier
Yvon A
YA
Deckelbaum
Richard J
RJ
D000818:Animals; D005217:Fat Emulsions, Intravenous / Q000493:pharmacokinetics*; D005260:Female; D005395:Fish Oils / Q000494:pharmacology*; D008071:Lipoprotein Lipase / Q000502:physiology; D008657:Metabolic Clearance Rate; D051379:Mice; D008810:Mice, Inbred C57BL; D011092:Polyethylene Glycols / Q000494:pharmacology; D011973:Receptors, LDL / Q000502:physiology; D014280:Triglycerides / Q000494:pharmacology*
D005217:Fat Emulsions, Intravenous; D005395:Fish Oils; D011973:Receptors, LDL; D014280:Triglycerides; D011092:Polyethylene Glycols; D008071:Lipoprotein Lipase; C016811:tyloxapol